STOCKHOLM – Elekta’s (EKTA-B.ST) Nomination Committee for the Annual General Meeting 2027 has been appointed in accordance with the instructions for the Nomination Committee adopted by the Annual General Meeting 2024.
The Nomination Committee consists of:
The Nomination Committee will appoint one of its members as Chairman.
Shareholders wishing to submit proposals to Elekta’s Nomination Committee can do so by e-mail to Peter.Nyquist@elekta.com or by letter to:
Elekta AB (publ)
Att: Nomination Committee
P.O. Box 7593
SE-103 93 Stockholm
Sweden
In order for the Nomination Committee to be able to process any proposals constructively, these should be received by the Nomination Committee no later than June 4, 2027.
# # #
For further information, please contact:
Peter Nyquist, Head of Investor Relations
Tel: +46 70 575 2906, e-mail: Peter.Nyquist@elekta.com
Time zone: CET: Central European Time
About Elekta
Elekta is shaping the standard of care, together with healthcare providers, by developing precision radiation medicine that brings advanced radiotherapy into routine clinical practice. Our solutions support consistent, efficient and personalized care, addressing evolving patient needs. Through adaptive radiotherapy, precision treatment delivery and integrated workflows, Elekta supports care teams across a range of clinical settings. Each year more than 2 million patients are treated using Elekta solutions across 130 countries. Elekta is headquartered in Stockholm, Sweden, with over 4,000 employees and offices in more than 40 countries. The company is listed on Nasdaq Stockholm. For more information, visit elekta.com.